| +4.24 / +4.81%|
The 22 analysts offering 12-month price forecasts for Celgene Corp have a median target of 104.00, with a high estimate of 128.00 and a low estimate of 66.00. The median estimate represents a +12.60% increase from the last price of 92.36.
The current consensus among 25 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.